Aaron R Folsom1, James M Peacock, Eric Boerwinkle. 1. Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, United States. folsom@epi.umn.edu
Abstract
BACKGROUND: We hypothesized that variants in PCSK9 that lower LDL cholesterol levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD). METHODS: The Atherosclerosis Risk in Communities (ARIC) Study assessed risk factors and PCSK9 variants Y142X and C679X (relevant to blacks) and R46L (relevant to whites) in a cohort of 45-64-year olds in 1987-1989 (n=13,634). Prevalent PAD (n=619 cases) was defined by an ankle-brachial index <0.9 or a history of leg claudication. Incident PAD (n=895) was identified from 1987 to 1998 by the same PAD criteria or a PAD hospitalization. RESULTS: As expected, greater LDL cholesterol was a risk factor for prevalent and incident PAD. 2.4% of blacks and 3.1% of whites were carriers of one of the race-specific PCSK9 variants. Carriers had lower prevalence of PAD compared with non-carriers (2.3% vs. 4.6%). The corresponding age- and sex-adjusted odds ratio of PAD was 0.47 (95% confidence interval, 0.24-0.92). In contrast with the cross-sectional findings, there was no association between PCSK9 variants and incident PAD (age- and sex-adjusted hazard ratio, 1.09 (95% confidence interval, 0.76-1.57)). CONCLUSIONS: Our study provides mixed evidence that variation in PCSK9 may contribute to genetic risk of PAD.
BACKGROUND: We hypothesized that variants in PCSK9 that lower LDL cholesterol levels are associated with reduced prevalence and incidence of peripheral artery disease (PAD). METHODS: The Atherosclerosis Risk in Communities (ARIC) Study assessed risk factors and PCSK9 variants Y142X and C679X (relevant to blacks) and R46L (relevant to whites) in a cohort of 45-64-year olds in 1987-1989 (n=13,634). Prevalent PAD (n=619 cases) was defined by an ankle-brachial index <0.9 or a history of leg claudication. Incident PAD (n=895) was identified from 1987 to 1998 by the same PAD criteria or a PAD hospitalization. RESULTS: As expected, greater LDL cholesterol was a risk factor for prevalent and incident PAD. 2.4% of blacks and 3.1% of whites were carriers of one of the race-specific PCSK9 variants. Carriers had lower prevalence of PAD compared with non-carriers (2.3% vs. 4.6%). The corresponding age- and sex-adjusted odds ratio of PAD was 0.47 (95% confidence interval, 0.24-0.92). In contrast with the cross-sectional findings, there was no association between PCSK9 variants and incident PAD (age- and sex-adjusted hazard ratio, 1.09 (95% confidence interval, 0.76-1.57)). CONCLUSIONS: Our study provides mixed evidence that variation in PCSK9 may contribute to genetic risk of PAD.
Authors: Jill J F Belch; Eric J Topol; Giancarlo Agnelli; Michel Bertrand; Robert M Califf; Denis L Clement; Mark A Creager; J Donald Easton; James R Gavin; Philip Greenland; Graeme Hankey; Peter Hanrath; Alan T Hirsch; Jürgen Meyer; Sidney C Smith; Frank Sullivan; Michael A Weber Journal: Arch Intern Med Date: 2003-04-28
Authors: Jonathan Cohen; Alexander Pertsemlidis; Ingrid K Kotowski; Randall Graham; Christine Kim Garcia; Helen H Hobbs Journal: Nat Genet Date: 2005-01-16 Impact factor: 38.330
Authors: D Michael Hallman; Sathanur R Srinivasan; Wei Chen; Eric Boerwinkle; Gerald S Berenson Journal: Am J Cardiol Date: 2007-05-11 Impact factor: 2.778
Authors: Marileia Scartezini; Christina Hubbart; Ros A Whittall; Jackie A Cooper; Andrew H W Neil; Steve E Humphries Journal: Clin Sci (Lond) Date: 2007-12 Impact factor: 6.124
Authors: Mindy M Pike; Nicholas B Larson; Christina L Wassel; Kevin P Cohoon; Michael Y Tsai; James S Pankow; Naomi Q Hanson; Paul A Decker; Cecilia Berardi; Kristine S Alexander; Mary Cushman; Neil A Zakai; Suzette J Bielinski Journal: Thromb Res Date: 2017-02-24 Impact factor: 3.944
Authors: Deepak K Gupta; Amil M Shah; Davide Castagno; Madoka Takeuchi; Laura R Loehr; Ervin R Fox; Kenneth R Butler; Thomas H Mosley; Dalane W Kitzman; Scott D Solomon Journal: JACC Heart Fail Date: 2013-04 Impact factor: 12.035
Authors: Deepak K Gupta; Hicham Skali; Brian Claggett; Rumen Kasabov; Susan Cheng; Amil M Shah; Laura R Loehr; Gerardo Heiss; Vijay Nambi; David Aguilar; Lisa Miller Wruck; Kunihiro Matsushita; Aaron R Folsom; Wayne D Rosamond; Scott D Solomon Journal: JACC Heart Fail Date: 2014-09-03 Impact factor: 12.035
Authors: Iris Postmus; Stella Trompet; Anton J M de Craen; Brendan M Buckley; Ian Ford; David J Stott; Naveed Sattar; P Eline Slagboom; Rudi G J Westendorp; J Wouter Jukema Journal: J Lipid Res Date: 2013-02 Impact factor: 5.922